Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,223
Total Claims
$5.4M
Drug Cost
900
Beneficiaries
$6,023
Cost/Patient
Risk Score Breakdown 22/100
Score components are additive. Read full methodology
Peer Comparison vs. 21,141 Psychiatry providers
+255%
Cost per patient vs peers
$6,023 vs $1,696 avg
+151%
Brand preference vs peers
12.4% vs 5.0% avg
Brand vs Generic
Brand: 2,391 claims · $4.7M
Generic: 16,832 claims · $744K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Valbenazine Tosylate | 216 | $1.7M |
| Lumateperone Tosylate | 304 | $562K |
| Aripiprazole | 142 | $421K |
| Aripiprazole Lauroxil | 109 | $346K |
| Brexpiprazole | 114 | $195K |
| Deutetrabenazine | 23 | $187K |
| Lurasidone Hcl | 90 | $157K |
| Iloperidone | 81 | $147K |
| Cariprazine Hcl | 97 | $147K |
| Vortioxetine Hydrobromide | 152 | $93K |
| Risperidone | 29 | $79K |
| Paliperidone Palmitate | 26 | $79K |
| Aripiprazole | 568 | $75K |
| Icosapent Ethyl | 230 | $75K |
| Asenapine Maleate | 109 | $73K |
Prescribing Profile
Patient Profile
65
Avg Age
65%
Female
1.43
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data